However, we still see areas of weakness in the portfolio, including upcoming patent losses and a highly uncertain pipeline due to the complexities of running CNS trials. Historically, the firm ...
Aside from its $4.7 billion homebuilding cash balance, it also has $2.9 billion available on its revolving credit facility (or $7.6 billion of total homebuilding liquidity) Given our long-term outlook ...